Dallas & Fort Price, Texas – (working wire) – Satori Capital, a diversified technique funding agency based on the ideas of aware capitalism, at the moment introduced the launch of a brand new enterprise targeted on transformational firms creating progressive psychological well being options.
Satori Neuro targets firms creating cutting-edge therapies and disruptive enterprise fashions to handle the world’s most important psychological well being challenges. Supporting this type of innovation aligns immediately with Satori’s purpose: to create, fund, and encourage companies that uplift humanity.
“We now have spent a major period of time and sources over the previous a number of years evaluating alternatives associated to psychological well being,” mentioned James Hadaway, chief funding officer and managing accomplice of Satori Alpha. “Since we strongly consider within the enormous potential of those progressive options, we determined that if we might discover the proper Chief Funding Officer to guide a targeted technique, we might discover it ourselves.”
In trying to find this ideally suited chief, Satori managers have targeted on the important thing qualities they consider are important to success on this evolving sector. This Chief Funding Officer will needn’t solely an impressive scientific and operational background, but additionally deep relationships with entrepreneurs and enterprise leaders, in addition to the power to behave as a trusted and value-adding accomplice for technique portfolio firms. Satori additionally sought an emphatic chief who was strongly aligned with Satori’s goal and core values.
An intensive search led to a frontrunner identical to that: Dr. Amy Cruz. Dr. Cross brings greater than 20 years of expertise in science, expertise and innovation, with a selected concentrate on neurotechnology and human efficiency. She is a former Normal Associate at Prime Movers Lab, a enterprise capital agency that invests in science-driven early-stage startups creating options to a few of the world’s most urgent issues. She was beforehand Chief Scientific Officer at utilized neuroscience analysis agency Optios, and has prior expertise as CTO of Cubic International Protection and as Program Director on the Protection Superior Analysis Initiatives Company (DARPA). Dr. Cross holds a Bachelor of Science in Cell and Structural Biology and a Ph.D. in neuroscience from the College of Illinois at Urbana-Champaign.
“Amy’s experience and subject material experience, mixed along with her spectacular skilled background, positions her ideally to guide this progressive neuroscience and psychological well being technique,” mentioned Randy Eisenman, Co-Founder and Managing Associate of Satori. “Along with the operational expertise of our administrators in constructing and managing profitable firms, we consider that Amy’s experience, expertise and distinctive relationships give us a definite benefit in figuring out promising and progressive companies on this sector.”
Satori’s evaluation of Dr. Cruz’s superiority in her area has resonated with entrepreneurs and enterprise leaders she has labored with in her earlier roles, together with Dr. Jonathan Sporn, CEO of Gilgamesh Prescription drugs, a clinical-stage biotech firm creating new medicines that harness remedy. The drug guarantees to revolutionize the therapy of psychological sickness.
“Amy is the proper collaborator, each as an investor and as a thought accomplice,” mentioned Sporn. You could have performed a serious position within the success of our firm, Gilgamesh Prescription drugs. Amy is without doubt one of the most dynamic individuals I’ve labored with in my profession, and he or she brings this vitality to her work investing in tasks by each interplay. It is scientifically astute, sensible and remarkably linked – any firm can be fortunate to share it.”
Underneath Dr. Cross’s route, Satori Neuro will search alternatives to handle the best psychological well being, mind well being, and wellness challenges and alternatives. The progressive therapies concerned embody a variety of therapy modalities, from anesthetic medication and transcranial magnetic stimulation to digital/augmented actuality protocols and non-invasive brainwave gadgets, all designed to supply options to challenges resembling treatment-resistant despair, post-traumatic stress issues, dependancy, substance abuse, neurological issues and extra. .
“That is an thrilling time for neuroscience and mind well being,” mentioned Dr. Cruz. “We now have realized extra in regards to the human mind up to now 5 years than we’ve beforehand realized up to now 50 – and this data is quickly translating into real-world functions that maintain the promise of remodeling our whole method to psychological well being challenges we’ve grappled with all through human historical past. I consider these improvements are the longer term. human flourishing, and I am thrilled to be partnering with a purpose-driven firm like Satori in supporting firms creating cutting-edge therapies and new enterprise fashions.”
About Satori Capital
Satori Capital is a Texas-based multi-strategy funding agency based on the ideas of acutely aware capitalism. The aim of the corporate is to create, fund, and encourage companies that uplift humanity. Satori enterprise companions in non-public fairness by majority and minority investments with management groups of EBITDA $5-$50 million firms that function with a long-term perspective, adhere to their mission or goal, and create worth for all stakeholders . Satori Alpha’s various funding platform, Satori Alpha, creates and manages custom-made portfolios designed to satisfy the distinctive objectives of refined non-public, household workplace, and institutional traders. Via the Satori XL Partnership Program, Satori companions with managers it believes are extremely expert in producing sustainable alpha and can leverage Satori’s expertise, relationships, and sources, all in help of constructing a thriving and lasting enterprise. Satori Environmental invests in securities affected by the worldwide vitality sector’s shift in direction of extra renewable sources. For extra info, please go to www.satoricapital.com.